ArticleAIDS (London, England)2016

Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing.

Joseph M Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.